Life Science Leader Magazine Supplements

CRO Leadership Awards 2014

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link:

Contents of this Issue


Page 32 of 45

QUALITY RELIABILITY PRODUCTIVITY REGULATORY INNOVATION K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2014 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2014 31 "We are so proud to have been selected in all five categories of regulatory, reliability, productivity, quality, and innovation for the 2014 Life Science Leader magazine's Leadership Award. It is a testa- ment to the commitment of our professionals, who are dedicated to anticipating and exceeding our customers' needs. At Quintiles we are focused on transforming the delivery of clinical research, and we are leading the industry to improve our customers' probability of success." "RPS is honored to be recognized as a leader in providing the highest quality services in support of our partners' product development portfolios. Our talented team of highly experienced professionals has a passion for customer service and quality, and unwavering commitment to helping our part- ners bring innovative, life-changing therapeutics to patients in need. Our innovative approach has enabled RPS to partner with our clients to transform product development, creating a more efficient and sustainable model." "At SCYNEXIS we deliver innovative solutions that complement our customers' capabilities. Our expert team understands the drug development path and consistently delivers high-quality GMP material while meeting customer timelines. Being recognized in these categories is a reflection of our high standards of safety, quality, and GMP compli- ance. Our GMP facility has been FDA inspected twice with no 483 issued. It's a pleasure to see our expertise recognized by our peers." MAIN SERVICE AREAS: Bioanalytical, Clinical SERVICES & CAPABILITIES: Quintiles is the world's largest provider of biopharmaceutical development and commercial outsourcing services, with 28,000+ employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. THERAPEUTIC AREAS: Cardiovascular, central nervous system, diabetes & endocrinology, immunology, infectious diseases, internal medicine, oncology, translational oncology, pe diatrics, public health, and vaccines MAIN SERVICE AREAS: Clinical SERVICES & CAPABILITIES: RPS Strategic Solutions delivers customized clinical development services utilizing embedded strategies designed to manage large and midsize biopharmaceutical companies' pipeline portfolios more efficiently and with greater flexibility and control . THERAPEUTIC AREAS: Cardiovascular, CNS, endocrinology and metabolism, dermatology, gastroenterology, hematology, immunology, infectious diseases, oncology, pulmonary medicine, rheumatology, urology, and women's h ealth MAIN SERVICE AREAS: Preclinical SERVICES & CAPABILITIES: Process development: novel chemistries, small & nonsmall molecules, bioactive lipids, glycolipids; cGMP manufacture; analytical control of processes: impurity identification characterization, method development, phase- appropriate validation, ICH stability, final product release THERAPEUTIC AREAS: We have provided our expertise and support across multiple therapeutic areas. A few examples include but are not limited to: CNS, inflammation, anti- infectives, etc. PAULA BROWN STAFFORD President, Clinical Development HARRIS KOFFER, PHARM.D. President DR. YVES RIBEILL CEO CATEGORIES WON CATEGORIES WON CATEGORIES WON SCYNEXIS Durham, NC +1 919 544 8600 Clare Murray Key locations: Durham, NC RPS Strategic Solutions, A Division of PRA Fort Washington, PA +1 215 540 0700 Maria DiPietro Key locations: Asia Pacific, EMEA, The Americas Quintiles Durham, NC +1 866 267 4479 Key locations: United Kingdom and United States DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 2, Phase 3) DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical Drug Substance Production: Primary Process Development, Drug Substance Production 2 0 1 4 L S L C R O C o m p a n y P r o f i l e L a y o u t T h a t N i c e . i n d d 1 3 2014 LSL CRO Company Profile Layout That Nice.indd 13 2 / 1 9 / 2 0 1 4 1 : 2 3 : 3 2 P M 2/19/2014 1:23:32 PM

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Leadership Awards 2014